leadf
logo-loader
viewNaked Wines Plc

Naked Wines PLC - Director/PDMR Shareholding

RNS Number : 1569G
Naked Wines PLC
23 November 2020
 

RNS Number:

Naked Wines plc

 

For Immediate Release

23 November 2020

 

 

 

Naked Wines plc

(the "Company")

 

Director/PDMR Shareholding

Naked Wines plc announces that Nicholas Devlin, Chief Executive Officer, has bought the following ordinary shares of 7.5 pence each in the Company ("Ordinary Shares"):

Number of Ordinary Shares

Date of purchase

Price (pence)

3,892

20 November 2020

508.75

 

Following the purchase, Mr. Devlin's beneficial interest in the Company and that of persons closely associated with him will be 69,372 Ordinary Shares representing approximately 0.09% of the issued share capital of the Company.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

DIRECTOR/PDMR SHAREHOLDING

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Nicholas Devlin

 

2

Reason for the notification

 

a)

Position/status

 

Chief Executive Officer
Naked Wines plc

 

b)

Initial notification/ Amendment

 

Initial Notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Naked Wines plc

 

b)

LEI

 

213800IYPFIRRQQE9R62

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

Description of the financial instrument, type of instrument

 Identification code

 

Ordinary Shares of 7.5p

   
GB00B021F836

b)

Nature of the transaction

 

Purchase

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£5.0875

3,892

 

 

 

 

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

 

 

e)

Date of the transaction

 

20 November 2020

f)

Place of the transaction

 

London Stock Exchange (XLON); AIM Market

 

For further information, please contact:

Naked Wines plc

Nick Devlin, Chief Executive Officer

James Crawford, Chief Financial Officer

 

[email protected]

Investec
(NOMAD & Joint Corporate Broker)

David Flin / Carlton Nelson / Tejas Padalkar

 

Tel: 0207 597 5970

Jefferies International Limited
(Joint Corporate Broker)

Ed Matthews / Harry Clements

 

Tel: 0207 029 8000

Instinctif Partners (PR Agency)

Damian Reece / Guy Scarborough

Tel: 0207 457 2020 or 07917 178 920

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUOAKRRRUAURA

Quick facts: Naked Wines Plc

Price: -

Market: AIM
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Market report: FTSE falls as New York schools get set to close

FTSE 100 opened lower after a sell-off in the US sparked by New York mayor Bill de Blasio’s closure of schools in response to rising COVID-19 cases. London’s leading index dropped 47 points to 6,337 in early trading.   The COVID-19 vaccine being developed by Oxford University and...

on 19/11/20

4 min read